Abstract
Transmitters and hormones generate signals in target cells by interacting with a signal transducing protein or receptor. Receptors may be located in the cytosol, allowing for example, steroid and thyroid hormones to control gene transcription. However, the largest family comprises G-protein linked seven transmembrane spanning receptors located in the plasma membrane. In addition to the endogenous transmitter or hormone, selective drugs are continuously being developed that act via receptors or discrete recognition sites. Drugs may mimic the action of the endogenous transmitter by binding to a receptor to induce a biological response such as muscle contraction and therefore function as an agonist. At the other end of the spectrum, competitive antagonists bind to receptors without inducing a functional response themselves but block the action of an agonist or endogenous transmitter. It is difficult to differentiate between agonists and antagonists in a binding assay and both classes of compounds will therefore be referred to as ligands.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Selected references
Davenport AP, Kuc RE, Fitzgerald F, Maguire JJ, Benyman K, Doherty AM. [125I]-PD151242: a selective radioligand for human ETA receptors. Brit J Pharmacol 1994; 111:4–6.
Davenport AP, O’Reilly G, Kuc RE. Endothelin ETA and ETB mRNA and receptors expressed by smooth muscle in the human vasculature: majority of the ETA sub-type. Brit J Pharmacol 1995;114:1110–1116.
Peter MG, Davenport AP. Selectivity of [125I]-PD151242 for the human, rat and porcine endothelin ETA receptors in the heart. Brit J Pharmacol 1995; 114,297–302.
Bylund DB, Yamamura HI. Methods in receptor Binding. In: Yamamura HI, Enna S J, Kuhar MJ, editors. Methods in Neurotransmitter Receptor analysis. New York;Raven Press, 1990; 1–35.
Davenport AP, Beresford IJM, Hall MD, Hill RG, Hughes J. Quantitative autoradiography. In editors van Leeuwen FW, Buijs RM, Pool, CW, Pach, O. Molecular Neuroanatomy. Elsevier;Amsterdam. 1988;121–145.
Hulme EC, Birdsall NJM. Strategy and tactics in receptor binding studies. In:Hulme EC, editor. Receptor-ligand interactions. Oxford; IRL Press, 1992;63–176.
Hulme EC, Buckley NJ. Receptor preparations for binding studies. In:Hulme EC, editor. Receptor-ligand interactions. Oxford; IRL Press, 1992; 177–212.
Jones CR, Molenaar P, Summers RJ. New Views of human cardiac B-adrenoceptors, J Mol Cell Cardiol 1989:21;519–535.
Molenaar P, O’Reilly G, Sharkey A, Kuc RE, Harding DP, Plumpton C, Gresham G A, Davenport AP. Characterization and localization of endothelin receptor sub-types in the human atrioventricular conducting system and myocardium. Circ Res 1993;72:526–538
Munson PJ, Rodbard D. LIGAND: a versatile computerized approach for characterization of ligand bonding systems. Anal Biochem 1980; 107;220–239.
Munson PJ. LIGAND: a computerized analysis of ligand binding data. Methods Enzymol 1983;92;543–576.
Unnersall JR. Computer-assisted analysis of binding data. In: Yamamura HI, Enna S J, Kuhar MJ, editors. Methods in Neurotransmitter Receptor analysis. New York; Raven Press, 1990;37–68.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Kluwer Academic Publishers
About this chapter
Cite this chapter
Davenport, A.P., Russell, F.D. (1996). Radioligand Binding Assays: Theory and Practice. In: Mather, S.J. (eds) Current Directions in Radiopharmaceutical Research and Development. Developments in Nuclear Medicine, vol 30. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1768-2_11
Download citation
DOI: https://doi.org/10.1007/978-94-009-1768-2_11
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-7289-2
Online ISBN: 978-94-009-1768-2
eBook Packages: Springer Book Archive